← Return to Multifocal Adenocarcinoma of the lung, continual recurrences

Discussion
Comment receiving replies
@merpreb

@lls8000– Lumakras was only approved for people who have KRAS G12C and mutation prevalence in squamous NSCLC. Not plain KRAS

Jump to this post


Replies to "@lls8000- Lumakras was only approved for people who have KRAS G12C and mutation prevalence in squamous..."

Ahh, got it. There are so many variations. We certainly need more research and advances, we’ve come a long way, but have so far to go too. Hugs.

I will have to take a look at the type of KRAS I have and I did also wonder if the approval was based on staging. Now that I have surgery behind me for the nodules that we’re growing/changing, I can be armed with many questions after my next scan in Dec. thank you for comments.

  Request Appointment